Monitoring cytochrome P-450 activity during rabeprazole treatment in patients with gastresophageal reflux disease

Digestive Diseases and Sciences

Volumn 51, Issue 9, 2006, Pages 1602-1606

  Giannini, Edoardo G ^a   Savarino, Vincenzo ^a   Testa, Roberto ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

13C aminopyrine breath test; Liver function; Rabeprazole

Indexed keywords

AMINOPHENAZONE; CYTOCHROME P450; RABEPRAZOLE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BREATH ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME ACTIVITY; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; LIVER FUNCTION TEST; MALE; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT RESPONSE;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; AMINOPYRINE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-ULCER AGENTS; BENZIMIDAZOLES; BREATH TESTS; CASE-CONTROL STUDIES; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; OMEPRAZOLE; TREATMENT OUTCOME;

EID: 33748617165     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-005-9035-7     Document Type: Article

References (34)

1. Dulbecco P, Savarino V (2004) Optimizing symptom relief and preventing complications in adults with gastresophageal reflux disease. Digestion 69(Suppl 1):9-16
2. McColl KEL, Kennerley P (2002) Proton pump inhibitors - differences emerge in hepatic metabolism. Dig Liver Dis 34:461-467
3. Gerson LB, Triadafilopoulos G: Proton pump inhibitors and their drug interactions: and evidence-based approach. Eur J Gastroenterol Hepatol 13:611-616
4. Humpries TJ, Merritt GJ (1999) Review article: drug interactions with agents used to treat acid-related disease. Aliment Pharmacol Ther 13(Suppl 3):18-26
5. Ishizaki T, Horia Y (1999) Review article: cytochrome P450 and the metabolism of proton pump inhibitors - emphasis on rabeprazole. Aliment Pharmacol Pharmacol 13 (Suppl 3):27-36
6. Horn J (2004) Review article: relationship between themetabolism and the efficacy of proton pump inhibitors - focus on rabeprazole. Aliment Pharmacol Ther 20(Suppl 6):11-19
7. 13C-aminopyrine breath test. Dig Dis Sci 50:1207-1213
8. Armuzzi A, Candelli M, Zocco MA, Andreoli A, De Lorenzo A, Nista EC, Miele L, Cremonini F, Cazzato IA, Grieco A, Gasbarrini G, Gasbarrini A (2002) Review article: breath testing for human liver function assessment. Aliment Pharmacol Ther 16:1977-1996
9. Carlisle R, Galambos JT, Warren WD (1979) The relationship between conventional liver tests, quantitative function tests, and histopathology in cirrhosis. Dig Dis Sci 24:358-362
10. 14C-aminopyrine in liver disease. Dig Dis Sci 27:49-56
11. 13C-Aminopyrine breath test to evaluate severity of disease in patients with chronic hepatitis C virus infection. Aliment Pharmacol Ther 16:717-725
12. 13C]Aminopyrine breath test detects altered liver metabolism caused by low-dose oral contraceptives. Dig Dis Sci 40:2417-2422
13. 13C] aminopyrine breath test. Dig Dis Sci 46:133-139
14. Giannini E, Fasoli A, Botta F, Romagnoli P, Malfatti F, Chiarbonello B, Mamone M, Savarino V, Testa R (2003) Helicobacter pylori infection is associated with greater impairment of cytochrome P-450 liver metabolic activity in anti-HCV positive cirrhotic patients. Dig Dis Sci 48:802-808
15. 2-breath tests at the laboratory. In: Digestion-absorption. University Hospital Gasthuisberg, Leuven, Belgium, pp 43-54
16. Haycock G, Shwartz G, Wisotsky D (1978) Geometric method for measuring body surface area. J Pediatr 93:62-66
17. Robinson M, Fitzgerald S, Hegedus R, Murthy A, Jokubaitis L (2002) Onset of symptom relief with rabeprazole: a community-based, open-label assessment of patients with erosive esophagitis. Aliment Pharmacol Ther 16:445-454
18. Bytzer P, Blum A, De Herdt D, Dubois D (2004) The Trial Investigators: Six-month trial of on-demand rabeprazole 10 mg maintains symptom relief in patientswith non-erosive reflux disease. Aliment Pharmacol Ther 20:181-188
19. Carswell CI, Goa KL (2001) Rabeprazole. An update of its use in acid-related disorders. Drugs 61:2327-2356
20. Adachi K, Katsube T, Kawamura A, Takashima T, Yuki M, Amano K, Ishihara S, Fukuda R, Watanabe M, Kinoshita Y (2000) CYP2C19 genotype status and intragastric pH during dosing with lansoprazole or rabeprazole. Aliment Pharmacol Ther 14:1259-1266
21. Tutuian R, Katz PO, Castell DO (2000) A PPI is a PPI is a PPI; lessons from prolonged intragastric pH monitoring. Gastroenterology 118(Suppl 2):A17 (abstract)
22. Lew EA (1999) Review article: pharmacokinetic concerns in the selection of anti-ulcer therapy. Aliment Pharmacol Ther 13(Suppl 5):11-16
23. Collen MJ, Abdulian JD, Chen YK (1995) Gastresophageal reflux disease in the elderly: more severe disease that requires aggressive therapy. Am J Gastroenterol 90:1053-1057
24. Whitaker M (2002) Proton pump inhibitors in the elderly population. Eur J Gastroenterol Hepatol 14(Suppl 1):S5-S9
25. Hoyumpa AM, Trevino-Alanis H, Grimes I, Humpries TJ (1999) Rabeprazole: pharmacokinetic in patientswith stable, compensated cirrhosis. Clin Ther 21:691-701
26. Homma M, Itagaki F, Yuzawa K, Fukao K, Kohda Y (2002) Effects of lansoprazole and rabeprazole on tacrolimus blood concentration: case of a renal transplant recipient with CYP2C19 gene mutation. Transplantation 73:303-304
27. Itagaki F, Homma M, Yuzawa K, Nishimura M, Naito S, Ueda N, Ohkohchi N, Kohda Y (2004) Effect of lansoprazole and rabeprazole on tacrolimus pharmacokinetic in healthy volunteers with CYP2C19 mutations. J Pharm Pharmacol 56:1055-1059
28. Coutts RT, Su P, Baker GB (1994) Involvement of CYP2D6, CYP3A4, and other cytochrome P-450 isozymes in N-dealkylation reactions. J Pharmacol Toxicol Methods 31:177-186
29. Paolini M, Pozzetti L, Sapone A, Cantelli-Forti G (1998) Effect of licorice and glycyrrhizin on murine liver CYP-dependent monooxygenases. Life Sci 62:571-582
30. Niwa T, Sato R, Yabusaki Y, Ishibashi F, Katagiri M (1999) Contribution of human hepatic cytochrome P450s and steroidogenic CYP17 to the N-demethylation of aminopyrine. Xenobiotica 29:187-193
31. Bastien MC, Leblond F, Pichette V, Villeneuve JP (2000) Differential alteration of cytochrome P450 isoenzymes in two experimental models of cirrhosis. Can J Physiol Pharmacol 11:912-919
32. Wilkinson GR (2005) Drug metabolism and variability among patients in drug response. N Engl J Med 352:2211-2221
33. Giannini E, Romagnoli P, Fasoli A, Chiarbonello B, Malfatti F, Botta F, Risso D, Lantieri PB, Savarino V, Testa R (2000) Influence of Helicobacter pylori eradication therapy on 13C aminopyrine breath test:comparison among omeprazole-, lansoprazole-, or pantoprazole-containing regimens. Am J Gastroenterol 95:2762-2767
34. Lim PW, Goh KL (2004) Review article: efficacy and safety of rabeprazole in treating gastresophageal reflux disease. J Gastroenterol Hepatol 19(Suppl 3):S61-S68